Quotient And Vasa Begin Human Trials Of VS-041 For Novel Heart Failure Therapy
11 Sep 2024 //
PRESS RELEASE
Vasa Therapeutics’ Lead Drug Candidate Enters Clinical Trials
10 Sep 2024 //
CONTRACT PHARMA
Vasa Therapeutics Announces Closing of Seed Financing
03 Jan 2024 //
PR NEWSWIRE